Skip to main content
See every side of every news story
Published loading...Updated

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.33 Average Price Target from Brokerages

Summary by defenseworld.net
Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) have received an average recommendation of “Buy” from the five ratings firms that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Monday, October 6, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal